Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,507 | 70 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $322.06 | 17 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $221.12 | 7 | $0 (2024) |
| Alkermes, Inc. | $136.77 | 8 | $0 (2024) |
| Lundbeck LLC | $133.55 | 7 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $110.36 | 6 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $107.97 | 5 | $0 (2024) |
| Axsome Therapeutics, Inc. | $85.87 | 4 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $83.39 | 5 | $0 (2024) |
| Corium, LLC | $82.71 | 2 | $0 (2024) |
| Brainsway USA INC | $72.87 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $524.65 | 23 | ABBVIE INC. ($126.86) |
| 2023 | $582.87 | 24 | Janssen Pharmaceuticals, Inc ($201.97) |
| 2022 | $373.37 | 21 | ABBVIE INC. ($163.93) |
| 2021 | $26.21 | 2 | Alkermes, Inc. ($13.15) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.49 | General |
| Category: PSYCHIATRY | ||||||
| 09/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.69 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.62 | General |
| Category: PSYCHIATRY | ||||||
| 06/06/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: CNS | ||||||
| 05/28/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.24 | General |
| Category: PSYCHIATRY | ||||||
| 05/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Neuropsychiatry | ||||||
| 05/08/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Central Nervous System | ||||||
| 04/30/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Neuroscience | ||||||
| 03/27/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Central Nervous System | ||||||
| 03/19/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $32.75 | General |
| Category: Neurology | ||||||
| 03/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: PSYCHIATRY | ||||||
| 03/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.33 | General |
| Category: PSYCHIATRY | ||||||
| 02/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: NEUROSCIENCE | ||||||
| 02/27/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $61.22 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 02/20/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $31.55 | General |
| Category: Psychology/Psychiatric | ||||||
| 02/13/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: NEUROLOGY | ||||||
| 02/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: NEUROSCIENCE | ||||||
| 01/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: NEUROSCIENCE | ||||||
| 01/16/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $35.19 | General |
| Category: Neurology | ||||||
| 12/19/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: INSOMNIA | ||||||
| 12/13/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 56 | 216 | $30,740 | $13,704 |
| 2022 | 3 | 75 | 336 | $46,850 | $22,646 |
| 2021 | 6 | 250 | 720 | $100,068 | $45,661 |
| 2020 | 5 | 246 | 652 | $90,049 | $36,298 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 102 | $15,810 | $7,887 | 49.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 68 | $9,180 | $3,763 | 41.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 11 | 46 | $5,750 | $2,054 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 225 | $34,875 | $18,418 | 52.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 22 | 92 | $11,500 | $4,119 | 35.8% |
| 90785 | Psychiatric services complicated by communication factor | Office | 2022 | 15 | 19 | $475.00 | $108.37 | 22.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 105 | 363 | $56,265 | $29,210 | 51.9% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 41 | 147 | $18,375 | $6,752 | 36.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 38 | 38 | $14,212 | $5,729 | 40.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 14 | 15 | $4,035 | $1,708 | 42.3% |
| 90785 | Interactive complexity | Office | 2021 | 41 | 146 | $3,650 | $1,412 | 38.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 11 | $3,531 | $851.08 | 24.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 102 | 312 | $48,360 | $20,707 | 42.8% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 42 | 140 | $17,500 | $6,423 | 36.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 41 | 41 | $15,334 | $5,785 | 37.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 20 | 20 | $5,380 | $2,025 | 37.6% |
| 90785 | Interactive complexity | Office | 2020 | 41 | 139 | $3,475 | $1,358 | 39.1% |
About Nathan Jaisingh, NP
Nathan Jaisingh, NP is a Nurse Practitioner healthcare provider based in Orland Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649228701.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nathan Jaisingh, NP has received a total of $1,507 in payments from pharmaceutical and medical device companies, with $524.65 received in 2024. These payments were reported across 70 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,507).
As a Medicare-enrolled provider, Jaisingh has provided services to 627 Medicare beneficiaries, totaling 1,924 services with total Medicare billing of $118,309. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Psychiatric/Mental Health, Registered Nurse
- Location Orland Park, IL
- Active Since 05/04/2006
- Last Updated 01/05/2026
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1649228701
Products in Payments
- VRAYLAR (Drug) $322.06
- SPRAVATO (Drug) $221.12
- REXULTI (Drug) $181.51
- ARISTADA (Drug) $112.49
- Auvelity (Drug) $85.87
- UZEDY (Drug) $67.94
- CAPLYTA (Drug) $66.05
- NUEDEXTA (Drug) $62.40
- Azstarys (Drug) $61.22
- TRINTELLIX (Drug) $51.83
- INGREZZA (Drug) $37.90
- QUVIVIQ (Drug) $33.97
- VYVANSE (Drug) $31.56
- Austedo XR (Drug) $28.02
- LYBALVI (Drug) $24.28
- AZSTARYS (Drug) $21.49
- APLENZIN (Drug) $12.51
- AUSTEDO (Drug) $12.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Orland Park
Lauren Burns
Nurse Practitioner — Payments: $8,412
Ewa Blachowicz, Np,Apn, NP,APN
Nurse Practitioner — Payments: $6,599
Cristyn Savoia, Aprn, Cnp, APRN, CNP
Nurse Practitioner — Payments: $5,907
Holly Clark, N.p, N.P
Nurse Practitioner — Payments: $5,784
Lauren Gesell, Aprn, Cnp, APRN, CNP
Nurse Practitioner — Payments: $4,580
Cara O'brien
Nurse Practitioner — Payments: $3,796